Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/26206
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Zhu JW | - |
dc.contributor.author | Gonsalves CL | - |
dc.contributor.author | Issenman RM | - |
dc.contributor.author | Kam AJ | - |
dc.date.accessioned | 2021-02-14T05:43:25Z | - |
dc.date.available | 2021-02-14T05:43:25Z | - |
dc.date.issued | 2021-02 | - |
dc.identifier.issn | 1054-139X | - |
dc.identifier.issn | 1879-1972 | - |
dc.identifier.uri | http://hdl.handle.net/11375/26206 | - |
dc.description.abstract | PURPOSE: This study aimed to synthesize qualitative and quantitative data on the diagnosis and effective management of cannabinoid hyperemesis syndrome (CHS) in the adolescent population. METHODS: Using keywords, 1,334 studies published between December 1954 and December 2019 were extracted from MEDLINE via PubMed, Embase via OVID, CINAHL via EBSCO, Web of Science, and the Cochrane Library. Studies were evaluated by two independent reviewers using predetermined inclusion and exclusion criteria. RESULTS: The search yielded 148 studies for full-text review, of which 21 were included in this systematic review. A total of 10 articles were related to the diagnosis of CHS, while 11 articles discussed the treatment and management of adolescent cases of CHS. CONCLUSIONS: CHS in the adolescent population fulfills the major and minor diagnostic criteria of CHS in the adult population; however, in adolescent patients, CHS may present more frequently in females, with the earliest reported case presenting at age 15 years. There appears to be a substantial proportion (21%) of adolescent patients diagnosed with CHS that have a history of anxiety and depression; however, higher quality studies to assess the prevalence are warranted. Although haloperidol and topical capsaicin cream may provide symptom relief in isolated cases, complete cessation of cannabis use is currently the only known effective treatment. | - |
dc.publisher | Elsevier BV | - |
dc.subject | Adolescents | - |
dc.subject | Cannabinoid hyperemesis syndrome | - |
dc.subject | Cannabis | - |
dc.subject | Cyclic vomiting syndrome | - |
dc.subject | Marijuana | - |
dc.subject | Pediatrics | - |
dc.subject | Substance use | - |
dc.title | Diagnosis and Acute Management of Adolescent Cannabinoid Hyperemesis Syndrome: A Systematic Review | - |
dc.type | Article | - |
dc.date.updated | 2021-02-14T05:43:24Z | - |
dc.contributor.department | Pediatrics | - |
dc.identifier.doi | 10.1016/j.jadohealth.2020.07.035 | - |
Appears in Collections: | Pediatrics Publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
JPeds CVS Systematic Review 2019.pdf | 674.34 kB | Adobe PDF | View/Open |
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.